Progressive multifocal leucoencephalopathy in AIDS camouflaged with catatonia: A wolf in sheep's clothing

Pradeep Kumar1, M K Jain

  • 1Associate Professor, Department of Medicine, S.S. Medical College and Associated S.G.M. Hospital, Rewa, Madhya Pradesh.

Insights

Progressive multifocal leukoencephalopathy (PML) can mimic psychiatric disorders, presenting diagnostic challenges. Early HIV screening is crucial for patients with akinetic mutism, especially those at high risk.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Neurology

Background:

  • Progressive multifocal leukoencephalopathy (PML) presents diagnostic challenges, often mimicking psychiatric conditions like psychosis or dementia.
  • PML can manifest with negative symptoms, catatonia, and akinetic mutism, particularly in individuals with AIDS, even without obvious immunocompromise.
  • The subtle presentation of PML can delay diagnosis and appropriate treatment.

Purpose of the Study:

  • To highlight the diagnostic complexities of Progressive Multifocal Leucoencephalopathy (PML).
  • To emphasize the importance of thorough clinical, biochemical, and MRI evaluations in patients presenting with catatonia and akinetic mutism.
  • To underscore the necessity of HIV screening in specific neurological presentations.

Main Methods:

  • Case report analysis.
  • Review of clinical, biochemical, and MRI findings.
  • Discussion of diagnostic criteria and differential diagnoses.

Main Results:

  • The case illustrates that PML can present atypically, without clear signs of immunosuppression.
  • Akinetic mutism can be a key indicator for underlying conditions like HIV.
  • Comprehensive assessment is vital for accurate diagnosis.

Conclusions:

  • PML requires a high index of suspicion in patients with unexplained catatonia or akinetic mutism.
  • HIV screening should be considered in patients with akinetic mutism, particularly those with risk factors.
  • Integrated diagnostic approaches are essential for managing complex neurological and infectious conditions.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...